Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_assertion type Assertion NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_head.
- NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_assertion description "[In this study, we investigated the antitumor activity of a small-molecule survivin suppressant YM155 alone and in combination with alemtuzumab in a murine model of human ATL (MET-1).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_provenance.
- NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_assertion evidence source_evidence_literature NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_provenance.
- NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_assertion SIO_000772 23321252 NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_provenance.
- NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_assertion wasDerivedFrom befree-20140225 NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_provenance.
- NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_assertion wasGeneratedBy ECO_0000203 NP552800.RAD6_jgHlQPLrsHsouZYWXFYp8kC4GhPHka-Aibc6aJjQ130_provenance.